Stock listing
CPH Stock Price, News, Filings & Events — Cipher Pharmaceuticals Inc.
Selected listing: CPH · NEO · CAD · CA
This page tracks Cipher Pharmaceuticals Inc.'s CPH:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CPH:NEO. CPH:NEO is the stock-level entry point for investors researching Cipher Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cipher Pharmaceuticals Inc. is a public company listed on the Canadian stock market under the ticker CPH. The company has a market capitalization of approximately CAD 296.2 million. Cipher focuses on the development and commercialization of innovative pharmaceutical products.
- Ticker
- CPH:NEO
- Asset type
- Stock
- Market cap
- $259.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NEO
- Currency
- CAD
Cipher Pharmaceuticals Inc. CPH:NEO stock context
This page tracks Cipher Pharmaceuticals Inc.'s CPH:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CPH:NEO. CPH:NEO is the stock-level entry point for investors researching Cipher Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cipher Pharmaceuticals Inc. is a public company listed on the Canadian stock market under the ticker CPH. The company has a market capitalization of approximately CAD 296.2 million. Cipher focuses on the development and commercialization of innovative pharmaceutical products.
Latest news from Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
August 11, 2026
Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call
July 31, 2026
Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris®
July 6, 2026
Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
June 18, 2026
Cipher Pharmaceuticals Reports First Quarter Results
May 7, 2026
Cipher Pharmaceuticals Inc. earnings calls
Cipher Pharmaceuticals Inc. (CPH) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Cipher Pharmaceuticals Inc. (CPH) Q1 2026 Earnings Call
May 8, 2026 · Replay with transcript and chapters
Cipher Pharmaceuticals Inc. (CPH) Q4 2025 Earnings Call
March 13, 2026 · Replay with transcript and chapters
Cipher Pharmaceuticals Inc. (CPH) Q3 2025 Earnings Call
November 7, 2025 · Replay with transcript and chapters
Cipher Pharmaceuticals Inc. (CPH) Q2 2025 Earnings Call
August 8, 2025 · Replay with transcript and chapters
Cipher Pharmaceuticals Inc. (CPH) Q1 2025 Earnings Call
May 9, 2025 · Replay with transcript and chapters
Research Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for CPH:NEO.
Cipher Pharmaceuticals Inc. company profile
View the public company page for Cipher Pharmaceuticals Inc. on 6ix.
Cipher Pharmaceuticals Inc. news
Read company news and market updates connected to Cipher Pharmaceuticals Inc..
Cipher Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Cipher Pharmaceuticals Inc..
Alternate listings
CPH:TSX
CA · CAD
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
CPHRF:OTC
US · USD
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
PHE:GETTEX
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
A0B85L:LSX
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
A0B85L:LS
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
PHE:FWB
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
PHE:SWB
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
PHE:DUS
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.
PHE:MUN
DE · EUR
Alternate listing for Cipher Pharmaceuticals Inc.; the primary context on this page is CPH:NEO.